Table 1 |
||
|
Characteristics of the PR3/MPO-ANCA-positive patients with idiopathic and antithyroid DIDs |
||
| Patients with idiopathic vasculitides (n = 56) |
Patients with antithyroid DIDs (n = 16) |
|
|
|
||
| Female sex, n (%) |
29 (52) |
15 (94)* |
| Age, years |
52.8 ± 10.9 |
31 ± 9.8** |
| Range |
18–72 |
20–52 |
| Months between first complaints and ANCA detection |
3.8 ± 1.2 |
2.3 ± 1.1** |
| Graves' disease/Hashimoto thyroiditis, n |
0 |
13/3 |
| Propylthiouracil/methimazole, n |
0 |
12/4 |
|
|
||
|
Values represent either numbers of patients (%) or mean ± standard deviation. *p < 0.01, **p < 0.001. ANCA, antineutrophil cytoplasmic antibodies; DID, drug-induced autoimmune disease; MPO, myeloperoxidase; PR3, proteinase 3. |
||
|
Bonaci-Nikolic et al. Arthritis Research & Therapy 2005 7:R1072 doi:10.1186/ar1789 |
||
